Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1187088017 | Antianemia drug (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3726979016 | Medicinal product acting as antianemic agent (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3726980018 | Antianemic agent | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3726981019 | Antianaemic agent | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 40343015 | Antianemia drug | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 40345010 | Antianemia drug, NOS | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 40346011 | Blood forming drug, NOS | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 40347019 | Hematinic, NOS | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 40348012 | Hematopoietic drug, NOS | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 40349016 | Haematopoietic drug, NOS | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 40350016 | Blood forming drug | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 40351017 | Hematinic | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 40352012 | Hematopoietic drug | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 481795017 | Antianaemia drug | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 481796016 | Haematinic | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 481797013 | Haematopoietic drug | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 753627019 | Antianemia drug (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Antianaemic agent | Plays role | Antianaemic therapeutic role | true | Inferred relationship | Some | ||
| Antianaemic agent | Is a | Haematologic drug | false | Inferred relationship | Some | ||
| Antianaemic agent | Has active ingredient | Hematologic agent | false | Inferred relationship | Some | ||
| Antianaemic agent | Is a | Medicinal product categorised by therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Intrinsic factor concentrate preparation | Is a | False | Antianaemic agent | Inferred relationship | Some | |
| Iron-containing product | Is a | False | Antianaemic agent | Inferred relationship | Some | |
| Drugs used in megaloblastic anaemias | Is a | False | Antianaemic agent | Inferred relationship | Some | |
| Continuous erythropoietin receptor activator-containing product | Is a | False | Antianaemic agent | Inferred relationship | Some | |
| Eculizumab-containing product | Is a | False | Antianaemic agent | Inferred relationship | Some | |
| Poisoning by liver preparation AND/OR other antianaemic agent | Causative agent | False | Antianaemic agent | Inferred relationship | Some |
This concept is not in any reference sets
FHIR